Nucleic acid-loaded lipid-polymer nanohybrids as novel nanotherapeutics in anticancer therapy

References

• Rahman M, Ahmad MZ, Kazmi I, et al. Advancement in multifunctional nanoparticles for the effective treatment of cancer. Expert Opin Drug Deliv. 2012;9(4):367–381.
   PubMed Web of Science ®Google Scholar
• Ahmad MZ, Akhter S, Jain GK, et al. Metallic nanoparticles: technology overview & drug delivery applications in oncology. Expert Opin Drug Deliv. 2010;7(8):927–942.
   PubMed Web of Science ®Google Scholar
• Akhter S, Ahmad Z, Singh A, et al. Cancer targeted metallic nanoparticle: targeting overview, recent advancement and toxicity concern. Curr Pharm Des. 2011;17(18):1834–1850.
   PubMed Web of Science ®Google Scholar
• Rahman M, Ahmad MZ, Kazmi I, et al. Emergence of nanomedicine as cancer targeted magic bullets: recent development and need to address the toxicity apprehension. Curr Drug Discov Technol. 2012;9(4):319–329.
   PubMedGoogle Scholar
• Rahman M, Akhter S, Ahmad MZ, et al. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges. Nanomedicine (Lond). 2015;10(15):2405–2422.
   PubMed Web of Science ®Google Scholar
• Tan S, Li X, Guo Y, et al. Lipid-enveloped hybrid nanoparticles for drug delivery. Nanoscale. 2013;5:860–872.
   PubMed Web of Science ®Google Scholar
• Wang B, Zhang L, Bae SC, et al. Nanoparticle-induced surface reconstruction of phospholipid membranes. Proc Natl Acad Sci. 2008;105:18171–18175.
   PubMed Web of Science ®Google Scholar
• Mandal B, Bhattacharjee H, Mittal N, et al. Core– shell-type lipid–polymer hybrid nanoparticles as a drug-delivery platform. Nanomedicine. 2013;9:474–491.
   PubMed Web of Science ®Google Scholar
• D’Souza A, Shegokar R. Polymer: lipid hybrid nanostructures in cancer drug delivery: successesand limitations. New York, USA: Elsevier; 2016. Chapter 16, Nanoarchitectonics for smart delivery and drug targeting; p. 431–463.
   Google Scholar
• Hadinoto K, Sundaresan A, Cheow WS. Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013;85:427–443.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhao H, He L, et al. Aptamer density dependent cellular uptake of lipid-capped polymer nanoparticles for polyvalent targeted delivery of vinorelbine to cancer cells. RSC Adv. 2015;5:16931–16939.
   Web of Science ®Google Scholar
• Luk BT, Jack Hu CM, Fang RH, et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale. 2014;6:2730–2737.
   PubMed Web of Science ®Google Scholar
• Bershteyn A, Chaparro J, Yau R, et al. Polymer supported lipid shells, onions, and flowers. Soft Matter. 2008;4:1787–1791.
   PubMed Web of Science ®Google Scholar
• Tian B, Al-Jamal WT, Al-Jamal KT, et al. Doxorubicin-loaded lipid-quantum dot hybrids: surface topography and release properties. Int J Pharm. 2011;416:443–447.
   PubMed Web of Science ®Google Scholar
• Troutier AL, Delair T, Pichot C, et al. Physicochemical and interfacial investigation of lipid/polymer particle assemblies. Langmuir. 2005;21:1305–1313.
   PubMed Web of Science ®Google Scholar
• Tan S, Sasada T, Bershteyn A, et al. Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for antitumor immunotherapy. Nanomedicine. 2014;9:635–647.
   PubMed Web of Science ®Google Scholar
• Thevenot J, Troutier AL, David L, et al. Steric stabilization of lipid/polymer particle assemblies by poly (ethylene glycol)-lipids. Biomacromolecules. 2007;8:3651–3660.
   PubMed Web of Science ®Google Scholar
• Gurny R, Peppas N, Harrington D, et al. Development of biodegradable and injectable latices for controlled release of potent drugs. Drug Dev Ind Pharm. 1981;7:1–25.
   Web of Science ®Google Scholar
• Chan J, Zhang L, Yuet K, et al. PLGA– lecithin–PEG core–shell nanoparticles for controlled drug delivery. Biomaterials. 2009;30:1627–1634.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li K, Pan J, et al. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of docetaxel. Biomaterials. 2010;31:330–338.
   PubMed Web of Science ®Google Scholar
• Liu Y, Pan J, Feng SS. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Int J Pharm. 2010;395:243–250.
   PubMed Web of Science ®Google Scholar
• Valencia P, Basto P, Zhang L, et al. Single-step assembly of homogenous lipid−polymeric and lipid−quantum dot nanoparticles enabled by microfluidic rapid mixing. ACS Nano. 2010;4(3):1671–1679.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chan JM, Gu FX, et al. Self-assembled lipid–polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano. 2008;2:1696–1702.
   PubMed Web of Science ®Google Scholar
• Wang A, Yuet K, Zhang L, et al. ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation. Nanomedicine. 2010;5:361–368.
   PubMed Web of Science ®Google Scholar
• Fang RH, Aryal S, Hu CM, et al. Quick synthesis of lipid–polymer hybrid nanoparticles with low polydispersity using a single-step sonication method. Langmuir. 2010;26:16958–16962.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang L. Lipid–polymer hybrid nanoparticles: synthesis, characterization, and applications. Nano Life. 2010;1:163–173.
   Google Scholar
• Pranatharthiharan S, Patel M, D’Souza A, et al. Inorganic nanovectors for nucleic acid delivery. Drug Delivery Transl Res. 2013;3:446–470.
   PubMed Web of Science ®Google Scholar
• Kolishetti N, Dhar S, Valencia PM. engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci. 2010;107:17939–17944.
   PubMed Web of Science ®Google Scholar
• Su X, Wang Z, Li L, et al. Lipid–polymer nanoparticles encapsulating doxorubicin and 29-deoxy-5-azacytidine enhance the sensitivity of cancer cells to chemical therapeutics. Mol Pharm. 2013;10:1901–1909.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu CF, Iqbal S, et al. Responsive nanocarriers as an emerging platform for cascaded delivery of nucleic acids to cancer. Adv Drug Deliv Rev. 2017;115:98–114.
   PubMed Web of Science ®Google Scholar
• Zhong Q, Chinta DMD, Pamujula S, et al. Optimization of DNA delivery by three classes of hybrid nanoparticle/DNA complexes. J Nanobiotechnol. 2010;8:6–16.
   PubMedGoogle Scholar
• Kubota K, Onishi K, Sawaki K, et al. Effect of the nanoformulation of siRNA-lipid assemblies on their cellular uptake and immune stimulation. Int J Nanomedicine. 2017;12:5121–5133.
   PubMed Web of Science ®Google Scholar
• Tezgel O, Szarpak-Jankowska A, Arnould A, et al. Chitosan lipid nanoparticles (CS-LNPs): application to siRNA delivery. J Colloid Interface Sci. 2018;510:45–56.
   PubMed Web of Science ®Google Scholar
• Thanki K, Eetyelde DV, Geyer A, et al. Mechanistic profiling of the release kinetics of siRNA from lipidoidal polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration. J Control Release. 2019;310:82–93.
   PubMed Web of Science ®Google Scholar
• Barichello JM, Morishita M, Takayama K, et al. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev Ind Pharm. 1999;25(4):471–476.
   PubMed Web of Science ®Google Scholar
• Li J, He Y, Li W, et al. A novel polymer–lipid hybrid nanoparticle for efficient non-viral gene delivery. Acta Pharmacol Sin. 2010;31:509–514.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li F, Li Y, et al. Codelivery of Hif1alpha siRNA and gemcitabine via biocompatible lipid–polymer hybrid nanoparticles for effective treatment of pancreatic cancer. Biomaterials. 2015;46:13–25.
   PubMed Web of Science ®Google Scholar
• Li J, He YZ, Li W, et al. A novel polymer–lipid hybrid nanoparticle for efficient nonviral gene delivery. Acta Pharmacol Sin. 2010;31:509–514.
   PubMed Web of Science ®Google Scholar
• Shi J, Xu Y, Xu X, et al. Hybrid lipid–polymer nanoparticles for sustained siRNA delivery and gene silencing. Nanomedicine. 2014;10:897–900.
   PubMed Web of Science ®Google Scholar
• Shi J, Xiao Z, Votruba AR, et al. Differentially charged hollow core/shell lipid–polymer–lipid hybrid nanoparticles for small interfering RNA delivery. Angew Chem Int Ed Engl. 2011;50:7027–7031.
   PubMed Web of Science ®Google Scholar
• Gao LY, Liu XY, Chen CJ, et al. Core–shell type lipid/rPAA–Chol polymer hybrid nanoparticles for in vivo siRNA delivery. Biomaterials. 2014;35:2066–2078.
   PubMed Web of Science ®Google Scholar
• Colombo S, Cun D, Remaut K, et al. mechanistic profiling of the siRNA delivery dynamics of lipid–polymer hybrid nanoparticles. J Control Release. 2015;201:22–31.
   PubMed Web of Science ®Google Scholar
• Goldsmith M, Mizrahy S, Peer D. Grand challenges in modulating the immune response with RNAi nanomedicines. Nanomed. 2011;6:1771–1785.
   PubMed Web of Science ®Google Scholar
• Chan JM, Zhang L, Vuet KP, et al. PLGA–lecithin–PEG core–shell nanoparticles for controlled drug delivery. Biomaterials. 2009;30:1627–1634.
   PubMed Web of Science ®Google Scholar
• Aryal S, Hu CMJ, Zhang L. Polymeric nanoparticles with precise ratiometric control over drug loading for combination therapy. Mol Pharm. 2011;8:1401–1407.
   PubMed Web of Science ®Google Scholar
• Palange AL, Di Mascolo D, Carallo C, et al. Lipid–polymer nanoparticles encapsulating curcumin for modulating the vascular deposition of breast cancer cells. Nanomedicine. 2014;10:991–1002.
   PubMed Web of Science ®Google Scholar
• Zheng M, Gong P, Zheng C, et al. Lipid–polymer nanoparticles for folate-receptor targeting delivery of doxorubicin. J Nanosci Nanotechnol. 2015;15:4792–4798.
   PubMed Web of Science ®Google Scholar
• Margolis LB, Namiot VA, Kljukin LM. Magneto-liposomes: another principle of cell sorting. Biochim Biophys Acta. 1983;735:193–195.
   PubMed Web of Science ®Google Scholar
• Xin Y, Huang M, Guo WW, et al. Nano-based delivery of RNAi in cancer therapy. Mol Cancer. 2017;16:134.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Miyata K, Nomoto T, et al. siRNA delivery from triblock copolymer micelles with spatially-ordered compartments of PEG shell, siRNA-loaded intermediate layer, and hydrophobic core. Biomaterials. 2014;35(15):4548–4556.
   PubMed Web of Science ®Google Scholar
• Kaczmarek JC, Patel AK, Kauffman KJ, et al. Polymer-LipidNanoparticles for systemic delivery of mRNA to the lungs. Angew Chem Int Ed Engl. 2016;55(44):13808–13812.
   PubMed Web of Science ®Google Scholar
• Thanki K, Zeng X, Foged C. Preparation, characterization, and in vitro evaluation of lipidoid-polymer hybrid nanoparticles for siRNA delivery to the cytosol. Methods Mol Biol. 2019;1943:141–152.
   PubMedGoogle Scholar
• Thanki K, Zeng X, Justesen S, et al. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: a quality by design-based approach. Eur J Pharm Biopharm. 2017;120:22–33.
   PubMed Web of Science ®Google Scholar
• D’Angelo I, Costabile G, Durantie E, et al. HybridLipid/polymer nanoparticles for pulmonary delivery of siRNA: development and fate upon in vitro deposition on the human epithelial airway barrier. J Aerosol Med Pulm Drug Deliv. 2018;31(3):170–181.
   PubMed Web of Science ®Google Scholar
• Xue HY, Tran N, Wong HL. A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapy. Eur J Pharm Biopharm. 2016;108:68–75.
   PubMed Web of Science ®Google Scholar
• Bose R, Arai Y, Ahn JC, et al. Influence of cationic lipid concentration on properties of lipid–polymer hybrid nanospheres for gene delivery. Int J Nanomed. 2015;10:5367–5382.
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang C, Li B, et al. LipidPolymerHybrid Nanomaterials for mRNA Delivery. Cell Mol Bioeng. 2018;11(5):397–406.
   PubMed Web of Science ®Google Scholar
• Yasar H, Biehl A, De Rossi C, et al. Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles. J Nanobiotechnology. 2018 19;16(1):72.
   PubMedGoogle Scholar
• Cheow WS, Hadinoto K. Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles. Colloids Surf B Biointerfaces. 2011;85:214–220.
   PubMed Web of Science ®Google Scholar
• Feng SS, Zhao LY, Zhang ZP, et al. Chemotherapeutic engineering: vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168h in vivo. Chem Eng Sci. 2007;62:6641–6648.
   Web of Science ®Google Scholar
• Bose RJC, Ravikumar R, Karuppagounder V, et al. Lipid polymer hybrid nanoparticle mediated therapeutics delivery: advances and challenges. Drug Discov Today. 2017;22:1258–1265.
   PubMed Web of Science ®Google Scholar